SHARE

The global stereotactic surgery devices market revenue is expected to expand at a moderate CAGR over the forecast period. Rapidly improving healthcare infrastructure in various countries is a key factor expected to drive growth of the global stereotactic surgery devices market over the forecast period.

The global stereotactic surgery devices market report has been segmented on the basis of product type, application, and region. On the basis of product type, the target market is segmented into The gamma knife, line accelerator (LINAC) machines, proton beam, and Cyberknife. The line accelerator (LINAC) machines product type segment is expected to register significant share in terms of revenue over the forecast period, owing to increasing adoption and installation of this type of products. In addition, the CyberKnife product type segment is expected to account for highest CAGR over the forecast period, owing to increasing popularity, especially in developing countries. On the basis of application, the target market is segmented into brain tumor treatment, arteriovenous malformations treatment, parkinsons disease, epilepsy, and trigeminal neuralgia. The parkinsons disease application segment is expected to register significant share in terms of revenue over the forecast period, owing to increasing preference towards stereotactic surgery in the treatment of this disorder.

Request for the Sample Report Here: https://marketresearch.biz/report/stereotactic-surgery-devices-market/request-sample/

Based on the region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to be highest share in terms of revenue over the forecast period, owing to technological advancements and increasing patient’s awareness in various countries in this region. The market in Asia Pacific is expected to register significant growth in terms of CAGR over the forecast period, owing to improving healthcare infrastructure in developing countries in the region.

Key players operating in the global stereotactic surgery devices market include Alliance Oncology, LLC., Micromar Ind. Com. Ltda., ADEOR MEDICAL AG, Monteris Medical, Inc., Elekta AB (pub), Inomed Medizintechnik GmbH., adeor Medical AG, Modus Medical Devices Inc., Raysearch Laboratories, and Varian Medical Systems, Inc.

LEAVE A REPLY

Please enter your comment!
Please enter your name here